Status:
RECRUITING
Gradient-Echo Spectroscopic Imaging Study of Saturated Fat and Breast Cancer
Lead Sponsor:
NYU Langone Health
Conditions:
Breast Cancer
Eligibility:
FEMALE
25-99 years
Phase:
NA
Brief Summary
The role of fat in breast cancer development and growth has been studied extensively using body mass index, a measure of whole body fatness, and dietary fat intake in a number of epidemiological studi...
Detailed Description
The overarching goal of this study is to determine the role of saturated fatty acid in breast cancer development and growth. In this proposal, GSI will be used for non-invasive in vivo measurement of ...
Eligibility Criteria
Inclusion
- No contraindications to MRI scanning (pacemaker, implanted metallic objects, severe obesity or other condition that leads to difficulty lying in the magnet)
- No contraindication to gadolinium contrast agent (severe renal insufficiency (EGFR\<30), allergy to gadolinium) which will be injected for clinical exam
- Able and willing to provide informed consent
- Post-menopausal age \> 25 years.
Exclusion
- Contra-indication to MRI or gadolinium contrast agent (have a pacemaker, aneurysm clip, or other metallic implant; weigh \>135 kg; or have renal impairment)
- Breast surgery within prior 12 months, or breast implants
- Any hormonal therapy
Key Trial Info
Start Date :
July 23 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 17 2025
Estimated Enrollment :
135 Patients enrolled
Trial Details
Trial ID
NCT03400215
Start Date
July 23 2018
End Date
April 17 2025
Last Update
April 1 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
NYU Langone Health
New York, New York, United States, 10016